U.S. probes anti-smoking medication
From Times Wire Reports
Government scientists are investigating whether a prescription drug by Pfizer Inc. used to help smokers quit cigarettes also increases suicidal thoughts and violent behavior.
The Food and Drug Administration said it had received reports of mood disorders and erratic behavior among patients taking Chantix.
The FDA advised doctors to closely monitor patients taking Chantix for behavior changes.
Start your day right
Sign up for Essential California for news, features and recommendations from the L.A. Times and beyond in your inbox six days a week.
You may occasionally receive promotional content from the Los Angeles Times.
